Outcome . | No beta-blocker n = 717 . | Beta-blocker n = 719 . | Hazard ratio (95% CI) . | P-value . |
---|---|---|---|---|
New AMI or all-cause mortality | 51 (7.1%) | 59 (8.2%) | 1.07 (0.73, 1.57) | 0.7 |
New AMI | 29 (4.0%) | 33 (4.6%) | 1.04 (0.63, 1.72) | 0.9 |
All-cause mortality | 24 (3.3%) | 30 (4.2%) | 1.13 (0.66, 1.95) | 0.7 |
Readmission due to heart failure | 7 (1.0%) | 5 (0.7%) | ||
Readmission due to atrial fibrillation | 6 (0.8%) | 4 (0.6%) |
Outcome . | No beta-blocker n = 717 . | Beta-blocker n = 719 . | Hazard ratio (95% CI) . | P-value . |
---|---|---|---|---|
New AMI or all-cause mortality | 51 (7.1%) | 59 (8.2%) | 1.07 (0.73, 1.57) | 0.7 |
New AMI | 29 (4.0%) | 33 (4.6%) | 1.04 (0.63, 1.72) | 0.9 |
All-cause mortality | 24 (3.3%) | 30 (4.2%) | 1.13 (0.66, 1.95) | 0.7 |
Readmission due to heart failure | 7 (1.0%) | 5 (0.7%) | ||
Readmission due to atrial fibrillation | 6 (0.8%) | 4 (0.6%) |
Values are n (%).
The P-values are derived from a χ2 test, a Wilcoxon rank sum test and Fisher’s exact test in that order.
Hazard ratios are derived from Cox regression models, adjusted for: age, sex, diabetes, previous AMI, and multi-vessel disease.
AMI, acute myocardial infarction.
Outcome . | No beta-blocker n = 717 . | Beta-blocker n = 719 . | Hazard ratio (95% CI) . | P-value . |
---|---|---|---|---|
New AMI or all-cause mortality | 51 (7.1%) | 59 (8.2%) | 1.07 (0.73, 1.57) | 0.7 |
New AMI | 29 (4.0%) | 33 (4.6%) | 1.04 (0.63, 1.72) | 0.9 |
All-cause mortality | 24 (3.3%) | 30 (4.2%) | 1.13 (0.66, 1.95) | 0.7 |
Readmission due to heart failure | 7 (1.0%) | 5 (0.7%) | ||
Readmission due to atrial fibrillation | 6 (0.8%) | 4 (0.6%) |
Outcome . | No beta-blocker n = 717 . | Beta-blocker n = 719 . | Hazard ratio (95% CI) . | P-value . |
---|---|---|---|---|
New AMI or all-cause mortality | 51 (7.1%) | 59 (8.2%) | 1.07 (0.73, 1.57) | 0.7 |
New AMI | 29 (4.0%) | 33 (4.6%) | 1.04 (0.63, 1.72) | 0.9 |
All-cause mortality | 24 (3.3%) | 30 (4.2%) | 1.13 (0.66, 1.95) | 0.7 |
Readmission due to heart failure | 7 (1.0%) | 5 (0.7%) | ||
Readmission due to atrial fibrillation | 6 (0.8%) | 4 (0.6%) |
Values are n (%).
The P-values are derived from a χ2 test, a Wilcoxon rank sum test and Fisher’s exact test in that order.
Hazard ratios are derived from Cox regression models, adjusted for: age, sex, diabetes, previous AMI, and multi-vessel disease.
AMI, acute myocardial infarction.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.